News - Press Releases

Cambrooke Therapeutics Metabolic Liquids and KetoVie Formulas are now OU-D Kosher Approved: The Only Manufacturer with Metabolic and Ketogenic Formula Products Certified.

November 1, 2018

AYER, Mass.--(BUSINESS WIRE)--Cambrooke Therapeutics Inc., a leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, continues to make breakthrough advancements for its customers. Cambrooke’s Glytactin GMP metabolic formulas and Ketogenic liquid formulas for people with intractable epilepsy have been OU-D certified by the Union of Orthodox Jewish Congregations of America (the “Orthodox Union”).

To become OU-D certified, a manufacturer must follow strict ingredient selection and product manufacturing guidelines and regulations. Having proven the purity of its ingredients and rigorous attention to quality in manufacturing, Cambrooke has earned the ability to include the world’s most popular kosher certification, OU-D Kosher, on packaging labels and product literature.

Cambrooke is the only manufacturer of metabolic and ketogenic diet therapy medical foods formulas to have the OU-D Kosher certification. The addition of this kosher certification enables more people to enjoy Cambrooke medical foods that are now proven to have been prepared in accordance to their beliefs. The OU-D emblem on Cambrooke metabolic liquid and KetoVie formula products is the latest demonstration of Cambrooke’s dedication to continually seeking ways to make its medical food products the best in meeting customer needs.

Cambrooke’s OU-D certified Glytactin formulas were designed to help meet the specialized nutritional needs of people with phenylketonuria (PKU), a rare genetic disorder requiring a life-long dietary restriction of all food items with regular dietary protein that contain an amino acid called phenylalanine (Phe). Cambrooke was the first to introduce a family of specialized formulas utilizing a natural source of safe protein and naturally fermented amino acids for these patients. Just prior to earning the OU-D Kosher certification, Cambrooke added new products to the Glytactin PKU family to include options featuring the most purified protein with lowest level of Phe and lowest calorie count.

Cambrooke’s OU-D certified KetoVie formulas are unique, ready-to-drink ketogenic formulas with a patented blend of key ingredients for the dietary management of intractable epilepsy. Cambrooke recently launched a highly innovative KetoVie Peptide product that is unlike any other in this category as it is nutritionally optimized for tube-fed patients and is the only option with a hypoallergenic protein source.

"My team is consistently looking at ways to improve our facility and enhance our products. This is just another step forward in demonstrating the quality of our products and in-house production of advanced nutrition. We are proud to have earned the OU-D kosher certification for these products and will continue to expand our certifications for many more products," said Steven Depew, Cambrooke’s senior vice president of manufacturing and operations.

About Cambrooke Therapeutics – Founded in 2000, Cambrooke Therapeutics, a proud member of The Ajinomoto Group, is a Massachusetts-based therapeutic nutrition company and global provider of medical nutrition products for patients with serious unmet medical needs. Cambrooke Therapeutics works with physicians and researchers from around the world to develop, test, and commercialize products that are focused on inborn errors of metabolism and intractable epilepsy. More information is available at cambrooke.com.

Contact

Cambrooke Therapeutics Inc. Elayna Rucker, 301-980-6594, erucker@cambrooke.com

Introducing Glytactin BUILD 20/20™ and Glytactin RTD Lite: The Lowest Phe GMP PKU Formulas Ever.

April 4, 2018

AYER, Mass.--(BUSINESS WIRE)--Cambrooke Therapeutics Inc., a leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, announces its latest breakthrough in Phenylketonuria (PKU) medical foods with the purest glycomacropeptide (GMP) based protein: Glytactin BUILD 20/20 and Glytactin RTD Lite 15.

These new PKU formulas feature Cambrooke’s next generation Glytactin with just 10 mg of phenylalanine (Phe) in every 10 grams of protein equivalent (PE). This is an average of 40% less Phe per gram of PE than all other GMP-based PKU medical foods.

This next generation Glytactin protein source has the purest (lowest Phe) GMP plus naturally fermented amino acids produced by The Ajinomoto Group. Glytactin BUILD 20/20 is the lowest Phe, lowest calorie, nutritionally complete Medical Food and has no sugars or artificial sweeteners. BUILD 20/20 has 20 grams of PE per single serve packet and is perfect for people living with PKU who have increased protein needs.

Results from a randomized, controlled, cross-over trial of Glytactin published in 2016 and 2017, led by researchers at the University of Wisconsin, Madison, suggest several key benefits when people with PKU consume Glytactin vs. amino acid medical foods. Some of these benefits include: feeling less hungry between meals and retaining more calcium and magnesium, key minerals that support bone health.

Glytactin RTD Lite 15 features Cambrooke’s next generation lowest Phe Glytactin in two delicious, nutritionally complete, ready-to-drink flavors—Coffee Mocha and Mild Vanilla. Each 8-oz. carton of RTD Lite 15 contains 15 grams PE with only 15 mg Phe and just 120 calories. RTD Lite 15 is an ideal way to get on-the-go convenience, great taste and the purest GMP-based medical food available.

Cambrooke’s Glytactin with GMP is made from a natural milk whey protein that, in its pure form, contains no Phe. The process of separating GMP from other milk whey proteins results in some residual Phe remaining in the GMP. The introduction of Cambrooke’s GMP with 40% lower Phe follows Cambrooke’s acquisition by Ajinomoto, an expert in natural fermentation and filtration as well as production of pharmaceutical quality amino acids.

Cambrooke Therapeutics was the first company to provide individuals with PKU natural whole protein medical foods — beginning in 2010 with Glytactin BETTERMILK. Cambrooke, now a proud member of The Ajinomoto Group, continues to provide people with PKU with a range of medical formula options including ready-to-drink Glytactin RTD and Glytactin RESTORE, Glytactin COMPLETE bars, Glytactin SWIRL dessert mix, and Glytactin BUILD 10 powder.

The PKU community welcomes this lowest Phe Glytactin. A metabolic dietitian wrote, "…for patients who have a low tolerance to Phe, this [Glytactin] allows them to comfortably take more of the formula then they may have been willing to take before."

Dione, who has PKU, commented, "The hardest time I have is maintaining my formula intake while still being mindful of calories—while still trying to build muscle. It's tough to do. That's why I just requested that Build 20/20 be added to my formula prescription. [It’s a] nice source of protein with low calories."

We are excited to leverage Ajinomoto’s strengths as we continue our mission at Cambrooke.

About Cambrooke Therapeutics – Founded in 2000, Cambrooke Therapeutics, a proud member of The Ajinomoto Group, is a Massachusetts-based therapeutic nutrition company and global provider of medical nutrition products for patients with serious unmet medical needs. Cambrooke Therapeutics works with physicians and researchers from around the world to develop, test, and commercialize products that are focused on inborn errors of metabolism and intractable epilepsy. More information is available at cambrooke.com.

Contact

Cambrooke Therapeutics Inc. Elayna Rucker, 301-980-6594, erucker@cambrooke.com

Ajinomoto Co. Inc. Acquires Cambrooke Therapeutics, Inc.

November 10, 2017

AYER, Mass.--(BUSINESS WIRE)--Cambrooke Therapeutics, Inc. (Cambrooke), a global leader and innovator in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, today announced it has been acquired by Ajinomoto Co. Inc. (Ajinomoto), a worldwide leader in amino acids, pharmaceuticals, high-quality seasonings, processed foods, beverages, and specialty chemicals, through its subsidiary Ajinomoto North America, Inc. Prior to the acquisition, Cambrooke was a privately-held business led by investors Galen Partners and Seventure Partners.

Cambrooke’s product portfolio serves the needs of people with chronic health conditions reliant on medical foods and specialized functional foods as a central part of their daily nutritional needs. With this acquisition, Cambrooke gains access to Ajinomoto’s global nutrition and ingredient sciences expertise, as well as proven flavor and texture-enhancing R&D capabilities.

According to Cambrooke President and Chief Executive Officer Howard Lossing, "Ajinomoto’s corporate motto of "Eat Well, Live Well." is an elegant statement that directly reflects Cambrooke’s mission of improving lives via providing the most delicious and most nutritious medical foods for people with chronic health conditions. In joining the Ajinomoto Group, our mission remains unchanged, our team remains in place, and our ability to better meet the needs of our customers expands with access to the enormous R&D capabilities of Ajinomoto."

For many decades Ajinomoto has contributed to global health and wellness through wide-ranging specialty applications of amino acid technologies. Today, the company is becoming increasingly involved in creating solutions for specialty nutrition, improved food resources and global sustainability. Ajinomoto’s acquisition of Cambrooke supports Cambrooke’s focus on specialty nutrition and enables a pathway for Cambrooke’s use of Ajinomoto’s core technologies on metabolic and ketogenic therapy products, as well as accelerated development of better nutritional solutions for more chronic conditions.

"Ajinomoto is deeply dedicated to improving lives through high-quality, good tasting nutrition," said Tatsuya Sato, President of Ajinomoto North America based in Chicago, IL. "We looked at many companies in recent years to help us grow in medical nutrition. The team at Cambrooke has been very successful in growing faster than other companies by better meeting the nutritional needs of the customers they serve. This success reflects a shared core value and led to our strong interest in Cambrooke joining the Ajinomoto Group."

Cambrooke co-founder Lynn Paolella said, "I am delighted to join Ajinomoto and to leverage Ajinomoto’s expertise. I have been developing specialty low protein products and medical foods for over 20 years, as well as preparing meals at home for my two children with phenylketonuria (PKU). Adding Ajinomoto’s ingredient, flavor and nutrition know-how to Cambrooke’s growing family of products makes the future brighter for all families touched by chronic health conditions."

About Ajinomoto North America, Inc. - Ajinomoto North America, Inc. is a wholly owned subsidiary of Ajinomoto Co., Inc. and is a recognized global leader in the research, development, manufacture and sale of amino acid-based products for the pharmaceutical, nutraceutical, sports nutrition, health and beauty industries as well as food ingredients and consumer food products. The company opened its first American office in New York in 1917 and has since grown and expanded its presence, establishing offices and production facilities in North Carolina, Iowa and Illinois. Ajinomoto North America, Inc. leverages an international manufacturing, supply and distribution chain to bring the highest-grade products to customers. For more information on Ajinomoto North America, Inc., please visit www.ajinorthamerica.com.

About Cambrooke Therapeutics – Founded in 2000, Cambrooke Therapeutics is a private equity-backed, Massachusetts-based therapeutic nutrition company and global provider of medical nutrition products for patients with serious unmet medical needs. The company works with physicians and researchers from around the world to develop, test and commercialize products that are focused on inborn errors of metabolism and intractable epilepsy. More information is available at cambrooke.com.

Contact

Cambrooke Therapeutics Inc. Elayna Rucker, 301-980-6594, erucker@cambrooke.com

Introducing Tylactin™ COMPLETE Bars

April 25, 2017

AYER, Mass.--(BUSINESS WIRE)--Cambrooke Therapeutics Inc., an innovation leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, announces the launch of Tylactin COMPLETE Bars, a nutritionally complete medical food, available in a convenient portable format, for the dietary management of Tyrosinemia (TYR).

Tylactin with GMP is made from a natural whole protein derived from whey called glycomacropeptide (GMP). Cambrooke Therapeutics was the first company to provide individuals with Tyrosinemia natural whole protein medical foods — Tylactin RTD and Tylactin RESTORE. Now, Tylactin COMPLETE Bars provides an additional option for individuals struggling to consume their formula or those people who need a compact, on-the-go, and great-tasting formula.

Each Tylactin COMPLETE Bar package contains three segments, each with 5g protein equivalents. This novel bar format is available in a delicious chocolate/peanut butter flavor. Tylactin COMPLETE Bars are an ideal addition to any TYR diet program for use at school, as a snack, or any time on-the-go convenience is desired.

"My son struggled to take all his formula every day," says Maria C., mother to a TYR child. "He does not want to finish it, and I have had to watch him carefully. This new Tylactin COMPLETE Bar is a joy for him, and I never have to worry about him finishing it. I am so thankful to Cambrooke for inventing such a wonderful product for my son."

About Cambrooke Therapeutics – Founded in 2000, Cambrooke Therapeutics is a private equity-backed, Massachusetts-based therapeutic nutrition company and global provider of medical nutrition products for patients with serious unmet medical needs. The company works with physicians and researchers from around the world to develop, test and commercialize products that are focused on inborn errors of metabolism and intractable epilepsy. More information is available at cambrooke.com.

Contact

Cambrooke Therapeutics Inc. Elayna Rucker, 301-980-6594, erucker@cambrooke.com

Introducing KetoVie Café Kwik Mix 4.5:1

November 28, 2016

AYER, Mass.--(BUSINESS WIRE)--Cambrooke Therapeutics Inc., an innovation leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, launches the long awaited baking mix, KetoVie Café Kwik Mix 4.5:1, to its popular line of a ketogenic foods.

KetoVie Café Kwik Mix 4.5:1 is easy to use and has the versatility to make a variety of your favorite baked goods, such as muffins, cookies and quick breads. As Cambrooke continues to extend its line of ketogenic diet-friendly products for those with intractable epilepsy, the company works tirelessly to ensure the products are convenient, tasty and packed with nutrition.

The smooth texture of the KetoVie Café Kwik Mix 4.5:1 was designed to be a quick-mix baking blend that can be used to create delicious recipes. Pancakes and waffles are just a few child-friendly foods that will be a hit among both kids and adults of any age. KetoVie Café Kwik Mix 4.5:1 is available in a 1.5-pound re-sealable bag and can be stored up to six months in the refrigerator, and has 1.1g of net carb and a 4.5:1 ketogenic ratio.

"My daughter Luella was all grins and smiles when she heard about the new mix and that she would be able to have ketogenic waffles on a regular basis. She still remembers the first time she tasted the KetoVie Café Waffle during the product development stages. The KetoVie Café Kwik Mix 4.5:1 is wonderful, and I look forward to the many everyday smiles to come when we use the Kwik Mix to make delicious recipes. The prep time to bake and try new things has made all the faces in the household cheer and smile," says Luella’s mother, Renee K.

KetoVie Café Kwik Mix 4.5:1 is available for direct purchase via ketovie.com or calling 866 456 9776.

About Cambrooke Therapeutics – Founded in 2000, Cambrooke Therapeutics is a private equity-backed, Massachusetts-based therapeutic nutrition company and global provider of medical nutrition products for patients with serious unmet medical needs. The company works with physicians and researchers from around the world to develop, test and commercialize products that are focused on inborn errors of metabolism and intractable epilepsy. More information is available at cambrooke.com.

Contact

Cambrooke Therapeutics Inc. Elayna Rucker, 301-980-6594, erucker@cambrooke.com

Introducing Burger Patty Mix and Chicken Patty Mix

September 27, 2016

AYER, Mass.--(BUSINESS WIRE)--Cambrooke Therapeutics Inc., an innovation leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, announces the introduction of two new low protein meat alternative foods: Burger Patty and Chicken Patty Dry Mixes.

Both the Cambrooke’s Burger Patty and Chicken Patty Mixes are deliciously seasoned and perfect for making meat alternative patties. They can also be used for other recipes such as tacos, stuffed peppers, meatballs, chili and more. Cambrooke’s Burger Patty Mix has 0.6g of protein and 21 mg of phe per ¼ cup (28 grams) and the Chicken Patty Mix has 0.5g of protein and 18 mg of phe per ¼ cup (35 grams) per serving.

Cambrooke’s Burger Patty and Chicken Patty Mixes contain only natural ingredients and flavors. Both come in convenient, resealable 1.5lb packages and are easily prepared just by mixing with water. Cambrooke’s Founder and Vice President of Food Innovation Lynn Paolella said, "While talking to parents and kids throughout the summer at camps and meetings, we learned that this product was in high demand. We immediately started to develop something that would not only taste great but also be nutritious. I enjoy cooking, talking with PKU patients and caregivers, and being able to continually innovate to meet the needs of PKU families. That is the heart of Cambrooke’s mission."

JoAnn, mother of an eight-year-old daughter with PKU, said, "I was talking to Lynn about meat alternative mixes just three short months ago in Indianapolis. To see it come to fruition so quickly is unbelievable. The texture and versatility of the patty mix is amazing. My entire family is excited about both products, and we look forward to traveling with these new food options during our upcoming holiday vacation."

About Cambrooke Therapeutics – Founded in 2000, Cambrooke Therapeutics is a private equity-backed, Massachusetts-based therapeutic nutrition company and global provider of medical nutrition products for patients with serious unmet medical needs. The company works with physicians and researchers from around the world to develop, test and commercialize products that are focused on inborn errors of metabolism and intractable epilepsy. More information is available at www.cambrooke.com.

Contact

Cambrooke Therapeutics Inc. Elayna Rucker, 301-980-6594, erucker@cambrooke.com

Introducing Tylactin RESTORE Powder for Tyrosinemia (TYR)

September 27, 2016

AYER, Mass.--(BUSINESS WIRE)--Cambrooke Therapeutics Inc., a leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, announces the launch of Tylactin™ RESTORE Powder, a medical food hydration beverage, available in convenient portable single-serve stick-packs for the dietary management of Tyrosinemia (TYR).

Tylactin with GMP is made from a natural whole protein derived from whey called glycomacropeptide (GMP). Cambrooke Therapeutics was the first company to provide individuals with Tyrosinemia natural whole protein medical foods—Tylactin RTD and Tylactin RESTORE. Now, Tylactin RESTORE Powder provides an additional option for individuals struggling to consume their formula or those people who need a compact, easy-to-mix, and great-tasting formula.

Tylactin RESTORE Powder contains 5g protein equivalents (PE). The formulation is a great option for those with an active lifestyle as it helps to replenish electrolytes lost during activities. Tylactin RESTORE Powder comes in an all-natural, great-tasting orange flavor. The stick-pack shape of the Tylactin RESTORE Powder packets makes them easy to mix into a bottle of water or an on-the-go sports bottle. Tylactin RESTORE Powder is an ideal addition to any TYR diet program for use at school, during sports or any time on-the-go convenience is desired.

"The formula options are so limited for the Tyrosinemia community. I continually struggled to take my formula," says Michael D., a teenager with TYR. "I never really liked my formula, but I had to take it because there was nothing else available. With the Tylactin products, I not only have a great tasting product, but it’s so convenient to take. I actually look forward to drinking my formula."

About Cambrooke Therapeutics – Founded in 2000, Cambrooke Therapeutics is a private equity-backed, Massachusetts-based therapeutic nutrition company and global provider of medical nutrition products for patients with serious unmet medical needs. The company works with physicians and researchers from around the world to develop, test and commercialize products that are focused on inborn errors of metabolism and intractable epilepsy. More information is available at www.cambrooke.com.

Contact

Cambrooke Therapeutics Inc. Elayna Rucker, 301-980-6594, erucker@cambrooke.com

Introducing Glytactin™ BUILD with the pH Balance of Water

September 22, 2016

AYER, Mass.--(BUSINESS WIRE)--Cambrooke Therapeutics Inc., a leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, announces the introduction of Glytactin BUILD, a unique medical food formula for the dietary management of Phenylketonuria (PKU). This latest addition to the glytactin family of PKU products was designed to enhance availability of the specialized glytactin protein for those on a low phenylalanine diet seeking more protein and fewer calories than traditional PKU Medical Foods.

At only 54 calories per 10 grams of Glytactin protein, Glytactin BUILD is the lowest calorie GMP-based formula available. With a complete profile of vitamins and minerals as well as probiotics to support digestive health, Glytactin BUILD is a versatile powder with a neutral flavor to be taken alone or as a way to build up the protein level of other PKU formulas or low protein food items. Glytactin BUILD has a pH equivalent to water that helps ease the GI distress associated with consuming traditional PKU formulas made from synthetically derived amino acids. Each convenient stick pack contains 10 grams of protein equivalent glytactin and is sold with 30 sticks per box.

"I started adding Glytactin BUILD to my current formula to boost the protein level and smooth out the amino acid burn," said Melinda S. "When I do, my stomach feels better, so I feel better."

"I want all my patients to use a more natural protein, but many of them have grown accustomed to the old-fashioned amino acid formula they grew up using," said a registered dietitian from a metabolic clinic on the west coast. "Glytactin BUILD is a great protein additive that lets me introduce natural protein into their diets while also taking care of their GI health and managing their caloric intake."

Glytactin is made from a natural whole protein derived from whey called glycomacropeptide (GMP), which is very low in phenylalanine. Published clinical evidence conducted at the University of Wisconsin, Madison, suggests intact proteins made with GMP have important benefits for patients with PKU versus traditional synthetic amino acid based formulas. These benefits include: improved taste, increased satiety, lower dietary acid load and improved protein utilization.

About Cambrooke Therapeutics – Founded in 2000, Cambrooke Therapeutics is a private equity-backed, Massachusetts-based therapeutic nutrition company and global provider of medical nutrition products for patients with serious unmet medical needs. The company works with physicians and researchers from around the world to develop, test and commercialize products that are focused on inborn errors of metabolism and intractable epilepsy. More information is available at www.cambrooke.com.

Contact

Cambrooke Therapeutics Inc. Elayna Rucker-Byers, 301-980-6594, erucker-byers@cambrooke.com

Launch of the all-new Glytactin™ Complete Bar

September 9, 2016

AYER, Mass.--(BUSINESS WIRE)--Cambrooke Therapeutics Inc., a leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, is pleased to announce a new and improved Glytactin Complete Bar, a Medical Food for the dietary management of Phenylketonuria (PKU).

The new and improved Glytactin Complete Bar contains glytactin with glycomacropeptide (GMP) with all the benefits of natural whole protein. The bars have the same nutrition as the previous bars, are still made in both 10-gram and 15-gram protein equivalents (PE) packages and are available in both Chocolate Peanut Butter and Fruit Frenzy flavor varieties.

The new version has enhancements that make the bar more enjoyable and convenient. First, the Glytactin Complete Bar is now thinner, making it less chewy. In addition, the Glytactin Complete Bar has been separated into 5-gram PE mini-bars; the 10-gram PE package contains two individual 5-gram bars. The 15-gram PE package contains three individual 5-gram bars

Glytactin Complete Bars are a great way to meet daily protein requirements as part of a complete PKU diet program. The convenient package format makes it ideal for use at school, work, vacations, sporting activities or any time simple convenience is desired. And now, with 5-gram mini-bar portions, one Glytactin™ Complete Bar can more easily be enjoyed at differing points in the day.

"The new Complete Bars taste great and are so much easier to eat," says Tiffany J., a child with PKU. Tiffany’s mom adds, "The old Complete Bar was too much for Tiffany to have at lunch, so I love being able to send her to school with one mini bar and saving the other portion for when she gets home from school."

About Cambrooke Therapeutics – Founded in 2000, Cambrooke Therapeutics is a private equity-backed, Massachusetts-based therapeutic nutrition company and global provider of medical nutrition products for patients with serious unmet medical needs. The company works with physicians and researchers from around the world to develop, test and commercialize products that are focused on inborn errors of metabolism and intractable epilepsy. More information is available at www.cambrooke.com.

Contact

Cambrooke Therapeutics Inc. Elayna Rucker-Byers, 301-980-6594, erucker-byers@cambrooke.com

Launches of Glytactin RESTORE Powder™ and Glytactin RESTORE Lite Powder™

September 9, 2016

AYER, Mass.--(EON: Enhanced Online News)--Cambrooke Therapeutics Inc., a leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, announces the launches of Glytactin RESTORE Powder™ and Glytactin RESTORE Lite Powder™, two medical food hydration beverages offered in convenient, portable, single-serve, stick-packs for the dietary management of Phenylketonuria (PKU).

Glytactin with GMP is made from a natural whole protein derived from whey called glycomacropeptide (GMP). Published clinical evidence conducted at the University of Wisconsin, Madison, suggests that intact proteins made with GMP have important benefits for patients with PKU versus traditional synthetic amino acid based formulas. These benefits include: improved taste, increased satiety, lower dietary acid load and improved protein utilization (van Calcar, S.C., MacLeod, E.L., Gleason, S.T., Etzel, M.R., Clayton, M.K., Wolff, J.A. and Ney, D.M. “Improved Nutritional Management of Phenylketonuria by Using a Diet Containing Glycomacropeptide Compared with Amino Acids.” The American Journal of Clinical Nutrition. 89:1068-1077, 2009; MacLeod E., Clayton M., van Calcar S., Ney D. “Breakfast with Glycomacropeptide Compared with Amino Acids Suppresses Plasma Ghrelin Levels in Individuals with Phenylketonuria.” Molecular Genetics and Metabolism. 2010: Vol. 100, Issue 4: 303-308).

Patient acceptance of metabolic medical food can be a challenge. A recently published study found that the overall acceptance of medical food with glytactin products was statistically higher than traditional synthetic amino acid based formulas (Clayton M., Levy H., Murali, S., Ney D., Rice, G. Rohr F., Stroup, B., “Glycomacropeptide for Nutritional Management of Phenylketonuria: a Randomized, Controlled, Crossover Trial.” The American Journal of Clinical Nutrition, 10.3945, 116.135293, 2016).

Glytactin RESTORE Powder contains 5g protein equivalents (PE) and Glytactin RESTORE Lite Powder contains 10g PE with 55% fewer calories than Glytactin RESTORE Powder per gram of PE. The formulation contains B vitamins and electrolytes, which are important for individuals with PKU that have an active lifestyle as they help to replenish electrolytes lost during activities. Glytactin RESTORE Powder comes in two all-natural, delicious berry and orange flavors. Glytactin RESTORE Lite Powder comes in an all-natural orange flavor. The stick-pack shape of the RESTORE Powder packets makes them easy to mix into a bottle of water or an on-the-go sports bottle. Glytactin Restore Powder is an ideal addition to any PKU diet program for use at school, sports or any time on-the-go convenience is desired.

"My son stays active playing soccer but struggles to take his PKU formula before practice because he gets an upset stomach after drinking his amino acid formula. In addition, the formula is difficult to measure and mix. The RESTORE Powder is an easy, quick option for him to both take his formula and stay hydrated at the same time,” says Linda K., a mom whose son has PKU."

About Cambrooke Therapeutics – Founded in 2000, Cambrooke Therapeutics is a private equity-backed, Massachusetts-based therapeutic nutrition company and global provider of medical nutrition products for patients with serious unmet medical needs. The company works with physicians and researchers from around the world to develop, test and commercialize products that are focused on inborn errors of metabolism and intractable epilepsy. More information is available at www.cambrooke.com.

Contact

Cambrooke Therapeutics Inc. Elayna Rucker-Byers, 301-980-6594, erucker-byers@cambrooke.com

Cambrooke Therapeutics Announces Launch of BetterMilk Lite

June 22, 2015 11:39 AM Eastern Daylight Time

AYER, Mass.--Cambrooke Therapeutics Inc., a leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, announces the introduction of BetterMilk Lite™, an advanced, lower calorie medical food formula containing its proprietary Glytactin™ with GMP for the dietary management of Phenylketonuria (PKU.

Cambrooke Therapeutics was the first to launch an intact protein formula, BetterMilk original, for patients with PKU, and now offers a reduced calorie, rich-in-flavor product, BetterMilk Lite. Glytactin with GMP is made from a natural whole protein derived from whey called glycomacropeptide (GMP). Published clinical evidence conducted at The University of Wisconsin, Madison, suggests that intact proteins made with GMP have important benefits for patients with PKU versus traditional synthetic amino acid based formulas. These benefits include: improved taste, increased satiety and improved protein utilization.

BetterMilk Lite, a lower calorie metabolic formula is available in convenient pre-measured powder packets with 20 grams of protein equivalent and 30% fewer calories than BetterMilk original. The formulation contains a complete nutritional profile including vitamins and minerals, DHA, and is the only GMP-based formula with both prebiotic fiber and probiotics to aid in digestion.

About Cambrooke Therapeutics – Founded in 2000, Cambrooke Therapeutics is a private equity-backed, Massachusetts-based therapeutic nutrition company and global provider of medical nutrition products for patients with serious unmet medical needs. The company works with physicians and researchers from around the world to develop, test and commercialize products that are focused on inborn errors of metabolism and intractable epilepsy. More information is available at www.cambrooke.com.

Contact

Cambrooke Therapeutics Inc. Elayna Rucker-Byers, 301-980-6594, erucker-byers@cambrooke.com